website translator plugin
A Division of ViaDerma, Inc. , A Public Company.

Breakthrough Rapid Delivery of Nutrients and Medicines

  • image wide 1

ViaDerma, Inc. is a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to stem-cell therapy.

About Us

ViaDerma, Inc. (QTCQB: VDRM) is a public specialty pharmaceutical company committed to bringing new products to market and licensing our innovative technology to current leaders in the pharmaceutical industry.

ViaDerma licenses our patent pending technology in a wide variety of therapeutic areas ranging from infectious diseases to wound care.

Technology

Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products.

Ability to enable active ingredients with a rapid transport direct to the site of action.

Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis.

Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life.

Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher.

Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing.

Our transdermal technology was used in a product which received the Bronze Award for “2012 Best New Pharmaceutical Product” at the 25th Annual Edison Awards in New York City

Named the winner of the “Drug Store News Best New Product” as voted by key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, NC.

USAGE & APPLICATION

Lead Product Tetrastem

World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results.

Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.

Very low water content and optimum (low) viscosity.

Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.

Potential markets

ViaDerma is developing products in many fields of use, including:

  • Topical antibiotics- $6 billion/year
  • Toenail antifungal drugs- $3 billion/year
  • Diabetic amputations- $3 billion/year
  • Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
  • Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
  • Eczema- $2.5 billion in 2014

Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management.

Case studies

Click the icon below to download PDF

News

Contact Details

ViaDerma's global headquarters is located at
8950 W. Olympic Blvd, Suite 576, Beverly Hills, CA 90211.

We are currently in discussions with companies in Australia & New Zealand, India, China, and West Africa.

Phone: 310.871.3996